Stock Events

Stock Events

Halozyme Therapeutics (HALO) Q1 2020 Earnings

24FebConfirmed

Q2 2019

Q3 2019

Q4 2019

Q1 2020

-0.24

-0.16

-0.07

0.01

Details

Expected EPS

-0.15

Actual EPS

-0.24

Surprise EPS

-0.09

Surprise Percent

+60%

Description

Halozyme Therapeutics (HALO) has reported earnings of -0.24 per share for Q1 2020.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.